Shares of Tempus AI, Inc. (TEM) jumped 17% on Monday morning after the company announced a new liquid biopsy assay intended to detect molecular response to immune-checkpoint inhibitor (ICI) therapy in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback